IL-6 modulates vascular function by upregulating the mRNA expression of the angiotensin II type 1 receptor, which then leads to greater angiotensin II-mediated vasoconstriction, greater free oxygen radical production (in vitro and in vivo), and the onset of endothelial dysfunction [45]. Here, IL6 is linked to endothelial dysfunction.